MiNK Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid Clinical Progress PNBK Q1 2019 Earnings Earnings Per Share Miss Estimates by Wide Margin OCUL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Development Revvity Q1 2026 Earnings EPS Surpasses Consensus Stock Slips on Missing Revenue Details SMBC Q1 2026 Earnings Earnings Slightly Miss Estimate Shares Edge Lower KR Q1 2026 Earnings EPS Beat Drives Modest Stock Gain